Their MYCN mRNA and protein levels exceed the levels of high-risk non-MNA tumours with poor outcome, but do not reach those of MNA tumours (Cohn et al, 2000; Tang et al, 2006; Westermann et al, 2008). Here, MYCN is linked to neoplasm.